Karamjit Gill - Concepedia

Author

Karamjit Gill

BC Cancer Agency

Also Known As

K. K. Gill, Karamjit Gill, Karamjit K Gill, Karamjit K. Gill

Publications

Citations

H-Index

Concepts

All Affiliations

BC Cancer Agency University of British Columbia

About

Karamjit Gill is an author at BC Cancer Agency specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	140
2	Immunology	3	3	93
3	Health Sciences	2	2	25
4	Pathology	2	2	82
5	Obstetrics	1	1	47

Karamjit Gill

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai, Blood	2006	1.5K
Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia Laurie H. Sehn, Jane Donaldson, Mukesh Chhanabhai, Journal of Clinical Oncology	2005	982
Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL) Pedro Farinha, Hamid Masoudi, Brian Skinnider, Blood	2005	455
Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma Abdulwahab J. Al-Tourah, Karamjit Gill, Mukesh Chhanabhai, Journal of Clinical Oncology	2008	369
The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation Pedro Farinha, Abdulwahab J. Al-Tourah, Karamjit Gill, Blood	2009	191
Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting Laurie H. Sehn, Jane Donaldson, Allison Filewich, Blood	2007	99
CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma Kenneth S. Wilson, Laurie H. Sehn, Brian Berry, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyLymphoid NeoplasiaAdverse Prognostic InfluenceHiv Negative DlbclChop Chemotherapy	2007	68
Management of idiopathic thrombocytopenic purpura in pregnancy Karamjit Gill, John G. Kelton Seminars in Hematology ThrombosisMaternal Cardiovascular OutcomeMedicineHematologyGynecology	2000	47
Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC) Laurie H. Sehn, Edward Hardy, Karamjit Gill, Blood	2014	32
Addition of Rituximab to CHOP Chemotherapy Significantly Improves Survival of Patients with Transformed Lymphoma. Abdulwahab J. Al-Tourah, Kerry J. Savage, Karamjit Gill, Blood	2007	26

Page 1